Literature DB >> 21960886

Review.

Usman Khokhar, Debra Stevens, Linda K Shipton, Daryl T-Y Lau.   

Abstract

Year:  2007        PMID： 21960886      PMCID： PMC3104264     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  41 in total

1.  Primary infection with a lamivudine-resistant hepatitis B virus.

Authors:  Vincent Thibault; Camille Aubron-Olivier; Henri Agut; Christine Katlama
Journal:  AIDS       Date:  2002-01-04       Impact factor: 4.177

2.  Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV.

Authors:  Huiling Yang; Xiaoping Qi; Alex Sabogal; Michael Miller; Shelly Xiong; William E Delaney
Journal:  Antivir Ther       Date:  2005

3.  Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic HBsAg carriers. A lack of relationship with serum markers of replication.

Authors:  F Davison; G J Alexander; R Trowbridge; E A Fagan; R Williams
Journal:  J Hepatol       Date:  1987-02       Impact factor: 25.083

4.  YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Authors:  S K Ono-Nita; N Kato; Y Shiratori; T Masaki; K H Lan; F J Carrilho; M Omata
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

5.  Inhibition of hepatitis B virus polymerase by entecavir.

Authors:  David R Langley; Ann W Walsh; Carl J Baldick; Betsy J Eggers; Ronald E Rose; Steven M Levine; A Jayne Kapur; Richard J Colonno; Daniel J Tenney
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

6.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Authors:  Eric E Mast; Cindy M Weinbaum; Anthony E Fiore; Miriam J Alter; Beth P Bell; Lyn Finelli; Lance E Rodewald; John M Douglas; Robert S Janssen; John W Ward
Journal:  MMWR Recomm Rep       Date:  2006-12-08

7.  A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.

Authors:  Ting-Tsung Chang; Robert G Gish; Stephanos J Hadziyannis; Janusz Cianciara; Mario Rizzetto; Eugene R Schiff; Giuseppe Pastore; Bruce R Bacon; Thierry Poynard; Shobha Joshi; Kenneth S Klesczewski; Alexandra Thiry; Ronald E Rose; Richard J Colonno; Robert G Hindes
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

8.  Hepatitis B vaccination. Response of alcoholic with and without liver injury.

Authors:  C Mendenhall; G A Roselle; L A Lybecker; L E Marshall; C J Grossman; S A Myre; R E Weesner; D D Morgan
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

9.  Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-11-22

10.  Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.

Authors:  Jeong Heo; Mong Cho; Hyung Hoi Kim; Young Min Shin; Hyun Jung Jang; Hee Kyung Park; Cheol Min Kim; Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Ung Suk Yang
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.